Caveolin-1 regulates contractility in differentiated vascular smooth muscle

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Je, Hyun Dong ^a   Gallant, Cynthia ^a   Leavis, Paul C ^a,b   Morgan, Kathleen G ^a,c  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Caldesmon; Decoy peptide; Extracellular signal regulated kinase 1 2; Signal transduction

Indexed keywords

CAVEOLIN 1; CHOLESTEROL; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PEPTIDE; PHORBOL ESTER; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FERRET; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0347628967     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00472.2003     Document Type: Article

References (47)

1. Bouillon M, El Fakhry Y, Girouard J, Khalil H, Thibodeau J, and Mourad W. Lipid raft-dependent and -independent signaling through HLA-DR molecules. J Biol Chem 278: 7099-7107, 2002.
2. Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, Mumby SM, Gilman AG, and Anderson RG. Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126: 127-138, 1994.
3. Chao TS, Foster DA, Rapp UR, and Rosner MR. Differential Raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbol esters, and calcium. J Biol Chem 269: 7337-7341, 1994.
4. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira De Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, and Lisanti MP. Caveolin-I null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 284: C457-C474, 2003.
5. D'Angelo G, Graceffa P, Wang CLA, Wrangle J, and Adam LP. Mammal-specific, ERK-dependent, caldesmon phosphorylation in smooth muscle. J Biol Chem 274: 30115-30121, 1999.
6. Dessy C, Kim I, Sougnez CL, Laporte R, and Morgan KG. A role for MAP kinase in differentiated smooth muscle contraction evoked by α-adrenoceptor stimulation. Am J Physiol Cell Physiol 275: C1081-C1086, 1998.
7. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, and Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
8. Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, and Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 22: 1267-1272, 2002.
9. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, and Lisanti MP. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428: 205-211, 1998.
10. Fowler L, Everitt J, Stevens JL, and Jaken S. Redistribution and enhanced protein kinase C-mediated phosphorylation of alpha- and gamma-adducin during renal tumor progression. Cell Growth Differ 9: 405-413, 1998.
11. Horowitz A, Menice CB, Laporte R, and Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev 76: 967-1003, 1996.
12. 2+ wave initiation move with caveolae to the trailing edge of migrating cells. J Cell Sci 115: 475-484, 2002.
13. Je HD, Gangopadhyay SS, Ashworth TD, and Morgan KG. Calponin is required for agonist-induced signal transduction-evidence from an antisense approach in ferret smooth muscle. J Physiol 537: 567-577, 2001.
14. Jiang MJ and Morgan KG. Agonist-specific myosin phosphorylation and intracellular calcium during isometric contractions of arterial smooth muscle. Pflügers Arch 413: 637-643, 1989.
15. Khalil RA, Menice CB, Wang CLA, and Morgan KG. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ Res 76: 1101-1108, 1995.
16. Khalil RA and Morgan KG. Protein kinase C: a second E-C coupling pathway in vascular smooth muscle? News Physiol Sci 7: 10-15, 1992.
17. Khalil RA and Morgan KG. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle activation. Am J Physiol Cell Physiol 265: C406-C411, 1993.
18. Kiley SC, Clark KJ, Duddy SK, Welch DR, and Jaken S. Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene 18: 6748-6757, 1999.
19. Kiley SC, Clark KJ, Goodnough M, Welch DR, and Jaken S. Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res 59: 3230-3238, 1999.
20. 2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta. J Physiol 526: 367-374, 2000.
21. Kimura K, Fukata Y, Matsuoka Y, Bennett V, Matsuura Y, Okawa K, Iwamatsu A, and Kaibuchi K. Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase. J Biol Chem 273: 5542-5548, 1998.
22. Lamb ME, Zhang C, Shea T, Kyle DJ, and Leeb-Lundberg LM. Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells. Biochemistry 41: 14340-14347, 2002.
23. Lee YH, Kim I, Laporte R, Walsh MP, and Morgan KG. Isozyme-specific inhibitors of PKC translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret. J Physiol 517: 709-720, 1999.
24. α subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996.
25. Liou JY, Deng WG, Gilroy DW, Shyue SK, and Wu KK. Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem 276: 34975-34982, 2001.
26. Lounsbury KM, Stern M, Taatjes D, Jaken S, and Mossman BT. Increased localization and substrate activation of protein kinase C delta in lung epithelial cells following exposure to asbestos. Am J Pathol 160: 1991-2000, 2002.
27. Menice CB, Hulvershorn J, Adam LP, Wang CLA, and Morgan KG. Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J Biol Chem 272: 25157-25161, 1997.
28. Morgan JP, DeFeo TT, and Morgan KG. A chemical procedure for loading the calcium indicator aequorin into mammalian working myocardium. Pflügers Arch 400: 338-340, 1984.
29. Morgan KG and Gangopadhyay SS. Invited Review: Cross-bridge regulation by thin filament-associated proteins. J Appl Physiol 91: 953-962, 2001.
30. Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, Ohno S, Couet J, Lisanti MP, and Ishikawa Y. Caveolin interaction with protein kinase C, Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 272: 33416-33421, 1997.
31. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
32. Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, and Insel PA. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62: 983-992, 2002.
33. Ruzycky AL and Morgan KG. Involvement of the protein kinase C system in calcium-force relationships in ferret aorta. Br J Pharmacol 97; 391-400, 1989.
34. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, and Lisanti MP. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272: 29337-29346, 1997.
35. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP, Chu C, and Kohtz DS. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93: 131-135, 1996.
36. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, and Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 270: 16395-16401, 1995.
37. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, and Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165, 1996.
38. Sukumaran SK, Quon MJ, and Prasadarao NV. Escherichia coli K1 internalization via caveolae requires caveolin-1 and protein kinase C alpha interaction in human brain microvascular endothelial cells. J Biol Chem 277: 50716-50724, 2002.
39. Taggart MJ. Smooth muscle excitation-contraction coupling: a role for caveolae and caveolins? News Physiol Sci 16: 61-65, 2001.
40. Taggart MJ, Leavis P, Feron O, and Morgan KG. Inhibition of PKCα and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide. Exp Cell Res 258: 72-81, 2000.
41. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, and Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 2255-2261, 1996.
42. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, and Alexander RW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276: 48269-48275, 2001.
43. Veldman RJ, Maestre N, Aduib OM, Medin JA, Salvayre R, and Levade T. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J 355: 859-868, 2001.
44. Voldstedlund M, Vinten J, and Tranum-Jensen J. Cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins. Cell Tissue Res 306: 265-276, 2001.
45. Wood KW, Sarnecki C, Roberts TM, and Blenis J. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041-1050, 1992.
46. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, and Lisanti MP. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277: 38988-38997, 2002.
47. Zimmerman AN and Hülsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211: 646-647, 1966.